WIGZELL HANS LENNART RUDOLF sold 31.5% of their position (10.50K shares) of SAREPTA THERAPEUTICS, INC. on the open market
Open‑market sale worth $1.31M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 12/16/2024ACC: 0000950170-24-136847
Director
Since Nov 2018
-10.50K
Net shares
Net seller
$1.31M
Total sold
1
Open market trades
0B · 1S
3
Total transactions
10.50K acquired · 21K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+10.50K
Price / share
$13.71
Trade value
$143.96K
% of position
46.0%
12/12/2024
22.84K→33.34K
Common Stock
Direct
Shares
−10.50K
Price / share
$124.84
Trade value
$1.31M
% of position
31.5%
12/12/2024
33.34K→22.84K
Total
Net shares
+0.00
Net value
-$1.17M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/12/2024 | M · Option Exercise | +10.50K | $13.71 | $143.96K | 46.0% | 22.84K | 33.34K |
| Common Stock Direct | 12/12/2024 | S · Sale | −10.50K | $124.84 | $1.31M | 31.5% | 33.34K | 22.84K |
| Total | +0.00 | -$1.17M | ||||||
Derivative Transactions1
Stock Options (right to buy)
Direct
Converts to
Common Stock
10.50K shares
Shares
−10.50K
Strike price
13.71
Held after
0.00
Exercisable
—
12/12/2024
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Options (right to buy) Direct | Common Stock10.50K shares | 12/12/2024 | M · Option Exercise | −10.50K | 13.71 | — | 0.00 |